Patent details

EP3053578 Title: COMBINATION CANCER THERAPY USING AZABICYCLO COMPOUND

  • Data
  • Documents

Basic Information

Publication number:
EP3053578
PCT Application Number:
JP2014075846
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148494479
PCT Publication Number:
WO2015046498
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION CANCER THERAPY USING AZABICYCLO COMPOUND
French Title of Invention:
POLYTHÉRAPIE CONTRE LE CANCER UTILISANT UN COMPOSÉ AZABICYCLO
German Title of Invention:
KOMBINATIONSTHERAPIE GEGEN KREBS MIT AZABICYCLO-VERBINDUNG
SPC Number:

Dates

Filing date:
29/09/2014
Grant date:
23/12/2020
EP Publication Date:
10/08/2016
PCT Publication Date:
02/04/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/12/2020
EP B1 Publication Date:
23/12/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/09/2021
Expiration date:
29/09/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/12/2020
 
 

Name:
Taiho Pharmaceutical Co., Ltd.
Address:
1-27 Kandanishiki-cho, Chiyoda-ku Tokyo 101-8444, Japan (JP)

Inventor

1

Name:
KANOH, Akira
Address:
Japan (JP)

2

Name:
MURAOKA, Hiromi
Address:
Japan (JP)

Priority

Priority Number:
2013205500
Priority Date:
30/09/2013
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 31/337; A61K 31/437; A61K 31/454; A61K 31/506; A61K 31/517; A61K 31/519; A61K 31/5377; A61K 31/704; A61K 31/7048; A61K 31/7068; A61P 35/00; A61K 33/24;

Publication

European Patent Bulletin

Issue number:
202052
Publication date:
23/12/2020
Description:
Grant (B1)
Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer: